[ Rising Tide Foundation for Clinical Cancer Research | Funding for clinical trials ]
Event details
| Date | 28.02.2020 |
| Category | Call for proposal |
The Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a Swiss-based non-profit organization, and the Anticancer Fund, a Belgian non-profit organization with an international scope, have joined forces to support clinical trials focusing on drug repurposing and therapy optimization, with special interest in the following areas:
- Rare cancers (<6/100,000)
- ‘Financial orphan’ drugs (commercially neglected drugs)
- Off patent drugs
- Prognostic and/or predictive biomarkers
This instrument is aimed at proposals where funding is required to initiate a new arm of an existing multi-arm trial. Additionally, proposals must have a strong rationale with rigorous and compelling supportive data, in addition to a detailed statistical design and methodology.
Funding: amount available for this call for proposals will be at least US$ 3 million. The amount allocated per grant will depend on the number of proposals selected for funding.
Deadline: 28 February 2020
Decision: 3rd quarter of 2020
For further information, please have a look at the call webpage.
Practical information
- General public
- Free